Simon Hoer

408 total citations
7 papers, 327 citations indexed

About

Simon Hoer is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Simon Hoer has authored 7 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Simon Hoer's work include Ubiquitin and proteasome pathways (3 papers), Viral-associated cancers and disorders (2 papers) and Mitochondrial Function and Pathology (2 papers). Simon Hoer is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Viral-associated cancers and disorders (2 papers) and Mitochondrial Function and Pathology (2 papers). Simon Hoer collaborates with scholars based in United Kingdom, Portugal and United States. Simon Hoer's co-authors include Paul J. Lehner, Lidia M. Duncan, Roger B. Dodd, William A. Müller, Jordan S. Pober, Thomas D. Manes, Benjamin J. Dunmore, Nicholas W. Morrell, Jun Yang and Hannah Durrington and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Simon Hoer

7 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Hoer United Kingdom 7 184 113 86 59 48 7 327
Sabina Pierpaoli Italy 12 230 1.3× 166 1.5× 76 0.9× 40 0.7× 65 1.4× 14 505
Sarah Irmscher Germany 3 225 1.2× 97 0.9× 68 0.8× 18 0.3× 27 0.6× 4 369
Hiromichi Gomi Japan 7 141 0.8× 94 0.8× 83 1.0× 20 0.3× 25 0.5× 21 316
P Jonveaux France 8 195 1.1× 136 1.2× 110 1.3× 21 0.4× 42 0.9× 10 471
Shijun Li China 7 165 0.9× 210 1.9× 45 0.5× 14 0.2× 36 0.8× 15 345
Jun Matsuzawa Japan 7 159 0.9× 101 0.9× 95 1.1× 66 1.1× 37 0.8× 11 378
Caroline Imbert France 7 126 0.7× 268 2.4× 278 3.2× 23 0.4× 39 0.8× 19 468
Isabel Boivin Canada 12 302 1.6× 61 0.5× 68 0.8× 69 1.2× 53 1.1× 20 536
Paola Marco‐Casanova United Kingdom 5 361 2.0× 207 1.8× 116 1.3× 49 0.8× 122 2.5× 11 457
Cornelia Thoeni Canada 7 155 0.8× 70 0.6× 23 0.3× 48 0.8× 42 0.9× 16 314

Countries citing papers authored by Simon Hoer

Since Specialization
Citations

This map shows the geographic impact of Simon Hoer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Hoer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Hoer more than expected).

Fields of papers citing papers by Simon Hoer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Hoer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Hoer. The network helps show where Simon Hoer may publish in the future.

Co-authorship network of co-authors of Simon Hoer

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Hoer. A scholar is included among the top collaborators of Simon Hoer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Hoer. Simon Hoer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Thomas, Luke W., Cinzia Esposito, Simon Hoer, et al.. (2019). CHCHD4 confers metabolic vulnerabilities to tumour cells through its control of the mitochondrial respiratory chain. SHILAP Revista de lepidopterología. 7(1). 2–2. 17 indexed citations
2.
Connor, Thomas M., Simon Hoer, Andrew J. Mallett, et al.. (2017). Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. PLoS Genetics. 13(3). e1006620–e1006620. 40 indexed citations
3.
Kiriakidis, Serafim, Simon Hoer, Natalie Burrows, et al.. (2017). Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor. Kidney International. 92(4). 900–908. 19 indexed citations
4.
Manes, Thomas D., Simon Hoer, William A. Müller, Paul J. Lehner, & Jordan S. Pober. (2010). Kaposi’s Sarcoma-Associated Herpesvirus K3 and K5 Proteins Block Distinct Steps in Transendothelial Migration of Effector Memory CD4+ T Cells by Targeting Different Endothelial Proteins. The Journal of Immunology. 184(9). 5186–5192. 34 indexed citations
5.
Durrington, Hannah, Paul D. Upton, Simon Hoer, et al.. (2010). Identification of a Lysosomal Pathway Regulating Degradation of the Bone Morphogenetic Protein Receptor Type II. Journal of Biological Chemistry. 285(48). 37641–37649. 55 indexed citations
6.
Hoer, Simon, et al.. (2006). MARCH‐IX mediates ubiquitination and downregulation of ICAM‐1. FEBS Letters. 581(1). 45–51. 52 indexed citations
7.
Lehner, Paul J., Simon Hoer, Roger B. Dodd, & Lidia M. Duncan. (2005). Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunological Reviews. 207(1). 112–125. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026